Quest Diagnostics Inc vs Five Below Inc — how do they compare? Quest Diagnostics Inc trades at $205.45 (market cap $22.95B), while Five Below Inc trades at $190 (market cap $10.59B). The key difference: Quest Diagnostics Inc is far larger — about 2.2× Five Below Inc's market cap, and Quest Diagnostics Inc pays a 1.66% dividend while Five Below Inc pays none. Which is the better fit depends on your goals.
| DGX | FIVE | |
|---|---|---|
Market Cap | $22.95B | $10.59B |
Sector | Health | Consumer Staples |
52-Week High | $216.02 | $247.71 |
52-Week Low | $166.42 | $131.94 |
Enterprise Value | $28.97B | $11.48B |
Dividend Yield | 1.66% | — |
Trailing returns across standard periods
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →Five Below is a value-oriented retailer that operated 1,190 stores in the United States as of the end of fiscal 2021. Catering to teen and preteen consumers, stores feature a wide variety of merchandise, the vast majority of which is priced below $6. The assortment focuses on discretionary items in several categories, particularly leisure (such as sporting goods, toys, and electronics
Read more on FIVE →